Medical Device Feasibility Study | Two Weeks, Fixed Price

You have an idea you can't cost and can't de-risk

In two weeks we tell you whether it can be built, how, and for how much — including when the answer is no.

Duration: 2 weeks
Price: Fixed, from $14,000
You own: Everything
Commitment after: None

Most good ideas die waiting to be evaluated

Every product company has a list of concepts it has discussed and parked. Not because they were bad — because nobody could answer the two questions that unlock a budget: can this actually be built, and what will it cost per unit?

Answering those questions properly needs engineers in disciplines you may not have in the building. Optics, electronics, firmware, injection tooling, the regulatory path for an active device. So the idea sits, and eventually someone else ships it.

A full development program is the wrong instrument here. It costs six figures and takes a year, and it asks you to commit before anyone knows whether there is anything to commit to.

Six workstreams, run in parallel

One team, one building, one joined-up answer

We diverge deliberately before we converge. The approach you arrived with is one candidate among several, and every candidate is tested by six specialist workstreams at the same time, sharing findings as the viable routes take shape.

Physics.

First-principles checks on whether each approach can work within its real-world constraints.

Manufacturability.

Processes, tolerances, materials, tooling, assembly and sourcing, examined from day one.

Indicative cost at volume.

Unit cost modeled at three production volumes, with the assumptions stated.

Regulatory pathway.

Likely classification, applicable standards and the evidence each route will require.

Preliminary patent-landscape review.

A focused engineering review of relevant public patents and prior art.

Prototype path & budget.

The smallest prototype sequence that retires the biggest risks, with a schedule and budget.

The patent-landscape review is an engineering assessment. It is not legal advice or a freedom to operate (FTO) opinion.

A decision, with the reasoning visible

Delivered as one document plus a review call with the engineers who did the work.

Every viable route, not just the obvious one

We diverge deliberately before we converge. The approach you arrived with is one candidate among several.

Each route scored against reality

Physics, manufacturability, cost at volume, the regulatory path and the patent landscape, scored in a matrix you can read and argue with.

Cost per unit at three volumes

So you can put the concept against your own margin structure rather than against a hope.

Two or three recommended routes, each with a prototype plan and budget

Priced, scheduled, and specific enough to take into a budget meeting.

A written recommendation

Our actual opinion, with the reasoning shown — not a menu handed back for you to choose from.

A review call with the engineers, not an account manager

The people who ran the analysis answer your questions directly.

Ten working days, start to answer

Day 1

Kick-off

One hour. You tell us the constraint that actually matters — cost, size, sterilization, the existing platform it has to live on.

Week 1

Divergence

Concept generation, prior-art and patent search, and first-principles checks on the approaches that look promising.

Week 2

Convergence

Scoring, costing at volume, regulatory path, and the prototype plan for the routes that survive.

Day 10

Decision

Document delivered, review call held. You own the file from that moment.

$14,000–$20,000, fixed before we start

The price is set by the scope of the question. No hourly billing, no overruns, no change orders inside the two weeks.

It is deliberately sized to sit inside a product manager's own authority. You should not need a capital request to find out whether your idea is buildable.

You own all of it, including the ideas

Every concept generated, every drawing, every calculation and the document itself transfer to you on delivery. We claim no residual rights and no royalty.

You are not committed to us for what comes next. If you take the study to another firm to build, that is a legitimate outcome, and the deliverable is written to be usable that way.

“There is no good path here” is a real deliverable

A study that concludes the concept should not be built has done its job. It cost you two weeks instead of a year.

We will say so plainly, and show the work behind it. A consultancy that never returns a negative answer is telling you something about its incentives rather than about your product.

Four situations where this is the right instrument

You have a concept on the roadmap that has been parked for more than a year.

Your product needs a discipline your engineering team doesn't cover — electronics, optics, firmware, or an active-device regulatory path.

You have been quoted a large development program and want the question de-risked before you commit to it.

A competitor has shipped something and you need to know, quickly and honestly, what it would take to answer it.

An engineering department you can hire by the phase

Kii.am designs and manufactures medical and dental devices in Kfar Saba, Israel. We are ISO 13485 and ISO 9001 certified, and devices we designed are in series production and on the market in the dental, veterinary and surgical fields today.

Mechanical, electronics, firmware, optics, quality and regulatory sit in one building, which is why a two-week study is possible at all. Most of our development work arrives as a full program. The study exists because the question in front of a client is often smaller than that, and deserves a smaller instrument.

Frequently Asked Questions

What exactly do we receive at the end of the two weeks?

One document and a review call. The document maps every viable route, scores each one across the six workstreams, gives cost per unit at three volumes, and recommends two or three routes, each with a prototype plan and budget. If no route is viable, it says so and shows why.

How is the price set?

The price is fixed before we start and set by the scope of the question, from $14,000 and typically up to $20,000. There is no hourly billing, and no change orders inside the two weeks.

Who owns the results?

You do. Every concept, drawing and calculation, and the document itself, transfer to you on delivery. We claim no residual rights and no royalty.

Do we have to continue with Kii.am afterwards?

No. You are not committed to us for what comes next. If you take the study to another firm to build, that is a legitimate outcome, and the deliverable is written to be usable that way.

Is the patent-landscape review a legal opinion?

No. It is a preliminary engineering review of relevant public patents and prior art, intended to shape the choice of route. It is not legal advice or a freedom to operate (FTO) opinion; for that, you would take the findings to patent counsel.

Start with the thing you parked

Tell us what's been sitting on your roadmap. Twenty minutes on a call is enough for both of us to know whether it's a study.

Medical Device Feasibility Study: Two Weeks, Fixed Price